Company Information

  

Address: 10 SYLVAN WAY  
City: PARSIPPANY 
State: NJ 
Zip Code: 07054 
Telephone: 973-822-7000 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

Zoetis Inc. is a global leader in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. We have a diversified business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals); and within five major product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. For more than 60 years, as a business unit of Pfizer Inc. (Pfizer), and since 2013 as an independent public company, we have been committed to enhancing the health of animals and bringing solutions to our customers who raise and care for them. We were incorporated in Delaware in July 2012. The address of our principal executive offices is 10 Sylvan Way, Parsippany, New Jersey 07054.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
09/20171.900.10533.56
06/20171.770.10535.24
03/20171.730.10530.85
12/20161.650.10532.44
09/20161.390.09537.42
06/20161.290.09536.79
03/20160.760.09558.33
12/20150.680.09570.47

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity1.35Total Liab/Total Assets0.81
Net Inc/Total Assets0.11Total Liab/Inv Cap0.94
Net Inc/Inv Cap0.13Total Liab/Comm Equity10.13
Pretax Inc/Net Sales0.25Interest Coverage Ratio8.40
Net Inc/Net Sales0.17Curr Debt/EquityNA
Cash Flow/Net Sales0.15LTD/Equity3.05
SG&A/NetSales0.28Total Debt/Equity3.05
Asset Utilization   Liquidity  
Net Receivables Turnover5.28Quick Ratio1.69
Inventory Turnover1.12Current Ratio3.03
Inventory Day Sales0.00Net Rec/Curr Assets0.27
Net Sales/Work Cap2.15Inv/Curr Assets0.44
Net Sales/PP&E3.54  

Income Statement (Millions)

  7/2/2017 4/2/2017 12/31/2016 10/2/2016
Total Revenues(Net Sales) 1,269.00 1,231.00 1,277.00 1,241.00
Cost of Goods Sold 440.00 443.00 468.00 410.00
Selling & Admin Exps 336.00 309.00 361.00 345.00
Operating Income 384.00 368.00 299.00 371.00
Interest Exp 41.00 41.00 41.00 41.00
Pretax Income 345.00 337.00 231.00 333.00
Other Income 2.00 10.00 -27.00 3.00
Net Income Bef Extraordinary ... NA NA NA NA
Net Income 247.00 238.00 154.00 239.00

Balance Sheet (Millions)

Assets 7/2/2017 4/2/2017 12/31/2016 10/2/2016
Cash & Short Term Investments 705.00 629.00 727.00 651.00
Receivables - Total 975.00 954.00 913.00 915.00
Inventories - Total 1,498.00 1,535.00 1,502.00 1,563.00
Total Current Assets 3,584.00 3,383.00 3,390.00 3,364.00
Net Property, Plant & Equipment 1,355.00 1,368.00 1,381.00 1,382.00
Total Assets 7,802.00 7,649.00 7,649.00 7,715.00
Liabilities        
Accounts Payable 902.00 949.00 1,076.00 997.00
Debt in Current Liabilities 850.00 750.00 0.00 0.00
Total Current Liabilities 1,784.00 1,730.00 1,117.00 1,039.00
Long-Term Debt 3,802.00 3,797.00 4,541.00 4,560.00
Total Liabilities 6,087.00 6,040.00 6,162.00 6,130.00
Stockholder's Equity        
Minority Interest 31.00 26.00 12.00 13.00
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 5.00 5.00 5.00 5.00
Retained Earnings 1,843.00 1,651.00 1,477.00 1,423.00
Treasury Stock -615.00 -510.00 -421.00 -351.00
Total Stockholders' Equity 1,715.00 1,609.00 1,487.00 1,585.00
Total Liabilities and Stockholders' Equity 7,802.00 7,649.00 7,649.00 7,715.00

Cash Flow Summary (Millions)

Categories 7/2/2017 4/2/2017 12/31/2016 10/2/2016
Net Cash Provided by Operating Activities 180.00 119.00 286.00 239.00
Net Cash Provided by Investing Activities -40.00 -48.00 -59.00 -124.00
Net Cash Provided by Financing Activities -64.00 -176.00 -128.00 -124.00

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20124,336.00436.00--
12/20134,561.00504.001.01
12/20144,785.00583.001.16
12/20154,765.00339.000.68
12/20164,888.00821.001.65
Growth Rates3.0417.14--

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/17810464,46195.32




Report Date : 12/11/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.